G. Steven Burrill
An introduction to Burrill Venture Capital
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech takes a beating in market meltdown October 01, 2008 | Press Release
Biotech outperforms market in May June 02, 2008 | Press Release
Biotech Treads Water in April May 01, 2008 | Press Release
See all News
Phytomedics uses a broad and innovative proprietary technology platform to discover, develop and manufacture novel, multi-component and multi-functional botanical therapeutics such as nutraceuticals and botanical drugs, as well as novel recombinant proteins. Through this proprietary technology platform, the Company has produced a pipeline of nutraceutical and pharmaceutical lead compounds, several of which are in clinical development.
For more information, please visit
